Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Bald men may have higher heart disease risk.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Adults with certain skin conditions may have higher levels of inflammation in their body.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.